Responsive Banner

Supply of our Type 2 Diabetes Medicines: Coronavirus (COVID-19) Update

We realise how unsettling the current situation is and that it may be triggering questions concerning the supply of medications that people rely on. Boehringer Ingelheim takes its responsibility towards safety and protection seriously. The health and well-being of our patients is at the core of everything we do and therefore continuing to supply our customers with the medications they need will continue to be our highest priority.

We are closely monitoring the situation and following the recommendations of the relevant Government and Health authorities.

For specific information on how to manage Type 2 Diabetes in relation to COVID-19 please see guidance from Diabetes UK here (by clicking here you are now leaving this website)



PC-GB-101497 Date of Preparation - March 2020